If you are in your late thirties, forties, or early fifties and your IBS symptoms have gotten noticeably worse — more unpredictable, more intense, harder to manage — and the changes seem to be tracking alongside other changes in your body and mood, you are not imagining it.
The hormonal transition of perimenopause has a direct, documented impact on gut function. And almost nobody talks about it.
Estrogen and Your Gut
Estrogen is not just a reproductive hormone. It plays a significant regulatory role in the gut-brain axis — influencing gut motility, visceral sensitivity, intestinal permeability, and the composition of the gut microbiome (Mulak et al., 2014).
When estrogen levels are stable, these systems tend to function with relative predictability. When estrogen begins to fluctuate — as it does during perimenopause, sometimes dramatically and unpredictably — the gut feels it.
Research shows that estrogen has a modulatory effect on the enteric nervous system, the network of neurons embedded in the gut wall that governs digestion. When estrogen drops, gut motility becomes less regulated. Visceral sensitivity — the gut’s pain and sensation threshold — tends to increase. The gut microbiome, which estrogen helps stabilize, begins to shift (Chen et al., 2021). For women who already have IBS, these changes can significantly amplify existing symptoms. For some women, perimenopause is when IBS-like symptoms appear for the first time.
The Stress Layer
Perimenopause does not just affect the gut directly through hormonal changes. It also tends to coincide with a period of significant life stress — aging parents, children leaving home, career transitions, relationship changes, questions about identity and purpose. Each of these is an independent stressor on the gut-brain axis.
The declining estrogen of perimenopause also affects the HPA axis — the body’s central stress-response system — making it less efficient at regulating cortisol (Mulak et al., 2014). This means that the same stressors that were manageable in your thirties may produce a larger, more sustained physiological response in your forties. And a larger cortisol response means more gut activation.
Sleep disruption, which is one of the most common and most distressing symptoms of perimenopause, compounds this further. As we know from the research, poor sleep elevates baseline cortisol, sensitizes the enteric nervous system, and sets up the morning gut reactivity that makes IBS in midlife feel so different from what it was before.
What This Means for Your Care
If your IBS is worsening during perimenopause, it is worth making sure your healthcare team understands the hormonal context — not because hormone management will solve IBS, but because the full picture informs better care.
From a gut-brain perspective, the nervous system dysregulation that perimenopause accelerates is exactly what brain-gut therapies address. Gut-directed CBT and gut-directed hypnotherapy work on the heightened visceral sensitivity and HPA axis dysregulation that drive perimenopausal gut flares, regardless of their hormonal origins (Lackner et al., 2018; Adler et al., 2025). MBSR has specific evidence for reducing stress reactivity in midlife women, with downstream benefits for both mood and gut symptoms (Altobelli et al., 2022).
You are not falling apart. Your body is going through a significant transition, and your gut is one of the places that transition is most acutely felt. Understanding that is the first step toward responding to it well.
About the author
Susan Liddy, MAMFT is a GI Psychotherapist and doctoral candidate in Integrative Health, specializing in nervous system-informed care for IBS and disorders of gut-brain interaction. Georgia residents are welcome to schedule a free consultation at www.susanliddy.com.
For educational purposes only. Not medical or psychological advice. Susan Liddy, MAMFT
References
Adler, E. C., Levine, E. H., Ibarra, A. N., Boparai, E. S., Hung, Y.-Y., McCrary, Q. D., & Lee, J. K. (2025). Gut-directed hypnotherapy for irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterology & Motility, 37(4), e70037. https://doi.org/10.1111/nmo.70037
Altobelli, E., Angeletti, P. M., Profeta, V. F., & Petrocelli, R. (2022). Meditation and irritable bowel syndrome: A systematic review and meta-analysis. Journal of Clinical Medicine, 11(21), 6516. https://doi.org/10.3390/jcm11216516
Chen, K. Y., Chen, Y., & Bernstein, C. N. (2021). The microbiome and sex hormones. Gastroenterology Clinics of North America, 50(2), 351–363. https://doi.org/10.1016/j.gtc.2021.02.002
Lackner, J. M., Jaccard, J., Keefer, L., Brenner, D. M., Firth, R. S., Gudleski, G. D., Hamilton, F. A., Katz, L. A., Krasner, S. S., Ma, C.-X., Radziwon, C. D., & Sitrin, M. D. (2018). Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology, 155(1), 47–57. https://doi.org/10.1053/j.gastro.2018.03.063
Mulak, A., Taché, Y., & Larauche, M. (2014). Sex hormones in the modulation of irritable bowel syndrome. World Journal of Gastroenterology, 20(10), 2433–2448. https://doi.org/10.3748/wjg.v20.i10.2433
